Lona Poole

Efficacy and Safety of Tifacogin (Recombinant Tissue Factor Pathway Inhibitor) in Severe Sepsis

Edward Abraham, Konrad Reinhart, Steven M. Opal et al. · JAMA · 2003 · 957 citations

Medicine, Pharmacology, Pharmacotherapy +15

Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group.

Edward Abraham, Antonio Anzueto, Guillermo Gutiérrez et al. · PubMed · 1998 · 628 citations

Pharmacy, Immunology, Inflammation +11

Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock

Edward Abraham, Antonio Anzueto, Guillermo Gutiérrez et al. · The Lancet · 1998 · 503 citations

Pharmacy, Immunology, Inflammation +12

Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study

Robert Provenzano, Anatole Besarab, Steven Charles Wright et al. · American Journal of Kidney Diseases · 2016 · 256 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Roxadustat (FG-4592)

Anatole Besarab, Igor Motylev, Evgeny Shutov et al. · Journal of the American Society of Nephrology · 2015 · 247 citations · Full text

Medicine, Hematology, Pharmacotherapy +17